Clinical trial
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour…
NCT00122252 · Alberta Health services, Other · Terminated
Key facts
| NCT number | NCT00122252 |
|---|---|
| Title | Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation |
| Official title | Biological Imaging for Optimising CTV and GTV Contouring in Prostate Cancer to Improve the Possibilities for IMRT Dose Escalation |
| Lead sponsor | Alberta Health services, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Prostate Cancer |
| Enrollment | 20 |
| Start date | May 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Jul 22, 2005 |
| Last update posted | Dec 9, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: